LifeStance Health Group, Inc. LFST
13.77 USD +0.34 (+2.53%)
At closeNov 6, 2026, 7:15 PM EST
13.97 +0.20 +1.45%
After hours · Nov 6, 7:15 PM ET
13.27 Day range 14.07
6.18 52-week range 14.21
- YTD
- +95.60%
- 1 year
- +120.32%
News
benzinga.com Canaccord Genuity Maintains Buy on LifeStance Health Gr, Raises Price Target to $16 Canaccord Genuity analyst Richard Close maintains LifeStance Health Gr (NASDAQ:LFST) with a Buy and raises the price target from $15 to $16.
benzinga.com Keybanc Maintains Overweight on LifeStance Health Gr, Raises Price Target to $17 Keybanc analyst Steve Dechert maintains LifeStance Health Gr (NASDAQ:LFST) with a Overweight and raises the price target from $15 to $17.
marketbeat.com What LifeStance Health Group (LFST) Said on Its Q3 Earnings Call LifeStance Health Group NASDAQ: LFST raised its full-year 2026 outlook after reporting 25% third-quarter revenue growth, driven by more patient visits and higher revenue per visit. The mental health…
benzinga.com BTIG Maintains Buy on LifeStance Health Gr, Raises Price Target to $20 BTIG analyst David Larsen maintains LifeStance Health Gr (NASDAQ:LFST) with a Buy and raises the price target from $18 to $20.
benzinga.com LifeStance Health Gr Q3 2026 Earnings Call Transcript LifeStance Health Gr (NASDAQ:LFST) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is…
zacks.com LifeStance Health Group (LFST) Tops Q3 Earnings and Revenue Estimates LifeStance Health Group (LFST) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to break-even earnings per share a year ago.- benzinga.com LifeStance Health Gr Sees Q4 Sales $446.000M-$466.000M vs $438.561M Est LifeStance Health Gr (NASDAQ:LFST) sees Q4 sales of $446.000 million-$466.000 million vs $438.561 million analyst estimate.
benzinga.com LifeStance Health Gr Raises FY2026 Sales Guidance from $1.685B-$1.725B to $1.741B-$1.761B vs $1.709B Est LifeStance Health Gr (NASDAQ:LFST) raises FY2026 sales outlook from $1.685 billion-$1.725 billion to $1.741 billion-$1.761 billion vs $1.709 billion estimate.
benzinga.com LifeStance Health Gr Q3 EPS $0.06 Beats $0.04 Estimate, Sales $455.900M Beat $431.816M Estimate LifeStance Health Gr (NASDAQ:LFST) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $0.04 by 50 percent. The company reported quarterly sales of $455.900…
globenewswire.com LifeStance Reports Strong Third Quarter 2026 Financial Results and Raises Full Year Outlook SCOTTSDALE, Ariz., Nov. 05, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial…
benzinga.com Transcript: LifeStance Health Gr Q2 2026 Earnings Conference Call LifeStance Health Gr (NASDAQ:LFST) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. Benzinga APIs provide real-time access to earnings…- benzinga.com Keybanc Maintains Overweight on LifeStance Health Gr, Raises Price Target to $15 Keybanc analyst Steve Dechert maintains LifeStance Health Gr (NASDAQ:LFST) with a Overweight and raises the price target from $13 to $15.
benzinga.com Barclays Maintains Overweight on LifeStance Health Gr, Raises Price Target to $15 Barclays analyst Peter Warendorf maintains LifeStance Health Gr (NASDAQ:LFST) with a Overweight and raises the price target from $13 to $15.
benzinga.com Canaccord Genuity Maintains Buy on LifeStance Health Gr, Raises Price Target to $15 Canaccord Genuity analyst Richard Close maintains LifeStance Health Gr (NASDAQ:LFST) with a Buy and raises the price target from $13 to $15.- benzinga.com LifeStance Prices 22.25M Share Secondary Offering At $12.35/Share; Co To Repurchase 2M Shares LifeStance Health Group, Inc. ("LifeStance" or the "Company") (NASDAQ:LFST), one of the nation’s largest providers of virtual and in-person outpatient mental health care, today announced the pricing…
benzinga.com BTIG Maintains Buy on LifeStance Health Gr, Raises Price Target to $18 BTIG analyst David Larsen maintains LifeStance Health Gr (NASDAQ:LFST) with a Buy and raises the price target from $16 to $18.
benzinga.com JP Morgan Maintains Neutral on LifeStance Health Gr, Raises Price Target to $13 JP Morgan analyst Lisa Gill maintains LifeStance Health Gr (NASDAQ:LFST) with a Neutral and raises the price target from $9 to $13.- benzinga.com BTIG Maintains Buy on LifeStance Health Gr, Raises Price Target to $16 BTIG analyst David Larsen maintains LifeStance Health Gr (NASDAQ:LFST) with a Buy and raises the price target from $15 to $16.
- benzinga.com LifeStance Health Gr Sees Q3 Sales $420.000M-$440.000M vs $418.474M Est LifeStance Health Gr (NASDAQ:LFST) sees Q3 sales of $420.000 million-$440.000 million vs $418.474 million analyst estimate.
- benzinga.com LifeStance Health Gr Raises FY2026 Sales Guidance from $1.640B-$1.680B to $1.685B-$1.725B vs $1.665B Est LifeStance Health Gr (NASDAQ:LFST) raises FY2026 sales outlook from $1.640 billion-$1.680 billion to $1.685 billion-$1.725 billion vs $1.665 billion estimate.
- benzinga.com LifeStance Health Gr Q2 EPS $0.06 Beats $0.04 Estimate, Sales $435.354M Beat $414.577M Estimate LifeStance Health Gr (NASDAQ:LFST) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $0.04 by 50 percent. This is a 700 percent increase over losses of…
- benzinga.com BTIG Maintains Buy on LifeStance Health Gr, Raises Price Target to $15 BTIG analyst David Larsen maintains LifeStance Health Gr (NASDAQ:LFST) with a Buy and raises the price target from $12 to $15.
benzinga.com Robinhood To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Tuesday Wall Street analysts change outlook on top names. See all rating changes, including upgrades and downgrades, on analyst ratings page.- benzinga.com Canaccord Genuity Maintains Buy on LifeStance Health Gr, Raises Price Target to $13 Canaccord Genuity analyst Richard Close maintains LifeStance Health Gr (NASDAQ:LFST) with a Buy and raises the price target from $11 to $13.
- benzinga.com Barclays Maintains Overweight on LifeStance Health Gr, Raises Price Target to $13 Barclays analyst Peter Warendorf maintains LifeStance Health Gr (NASDAQ:LFST) with a Overweight and raises the price target from $9 to $13.
- benzinga.com Keybanc Maintains Overweight on LifeStance Health Gr, Raises Price Target to $13 Keybanc analyst Steve Dechert maintains LifeStance Health Gr (NASDAQ:LFST) with a Overweight and raises the price target from $11 to $13.
- benzinga.com Goldman Sachs Initiates Coverage On LifeStance Health Gr with Neutral Rating, Announces Price Target of $9 Goldman Sachs analyst Scott Fidel initiates coverage on LifeStance Health Gr (NASDAQ:LFST) with a Neutral rating and announces Price Target of $9.
benzinga.com Forward Air Posts Downbeat Q1 Results, Joins Upwork, HubSpot And Other Big Stocks Moving Lower In Friday's Pre-Market Session U.S. stock futures up, Dow futures gain approx. 100 pts. Forward Air Corp (FWRD) shares down 42.8% in pre-market trading. Other stocks also down.
benzinga.com Forward Air Posts Downbeat Q1 Results, Joins Upwork, HubSpot And Other Big Stocks Moving Lower In Friday's Pre-Market Session U.S. stock futures up, Dow futures gain approx. 100 pts. Forward Air Corp (FWRD) shares down 42.8% in pre-market trading. Other stocks also down.
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session 
benzinga.com Earnings Scheduled For February 25, 2026 
benzinga.com Biohaven, Omeros And Other Big Stocks Moving Lower In Friday's Pre-Market Session 
benzinga.com SeaStar Medical, Jet.AI And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga.com Earnings Scheduled For November 6, 2025 - benzinga.com Earnings Scheduled For August 7, 2025
benzinga.com This Commercial Metals Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday - benzinga.com Earnings Scheduled For May 7, 2025
- benzinga.com Earnings Scheduled For February 27, 2025
- benzinga.com Earnings Scheduled For February 28, 2024 Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenue of $1.69 billion.
- benzinga.com Earnings Scheduled For November 8, 2023 Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its third quarter.
- benzinga.com Earnings Scheduled For August 9, 2023 Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is estimated to report quarterly earnings at $0.96 per share on revenue of $18.11 billion.
- benzinga.com Earnings Scheduled For May 10, 2023 Companies Reporting Before The Bell • Nomad Foods (NYSE:NOMD) is projected to report quarterly earnings at $0.42 per share on revenue of $851.81 million.
- benzinga.com Why Miromatrix Medical Shares Are Trading Lower By 40%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session Gainers Kimball International, Inc. (NASDAQ: KBAL) shares jumped 84.9% to $12.40 after HNI Corporation announced it will acquire the company for $485 million.
- benzinga.com Earnings Scheduled For March 8, 2023 Companies Reporting Before The Bell • Daktronics (NASDAQ:DAKT) is expected to report quarterly earnings at $0.00 per share on revenue of $164.68 million.
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 258 companies hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday Tuesday's session saw 325 companies set new 52-week lows.
- benzinga.com Why Merrimack Pharmaceuticals Shares Jumped Around 213%; Here Are 114 Biggest Movers From Yesterday Gainers
- benzinga.com Earnings Scheduled For November 8, 2022 Companies Reporting Before The Bell • Adtran (NASDAQ:ADTN) is likely to report quarterly earnings at $0.18 per share on revenue of $330.39 million.
- benzinga.com Earnings Scheduled For August 9, 2022 Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is estimated to report earnings for its second quarter.